Cheng Sohanya Roshan's Form 4 filing
Karyopharm Therapeutics Inc. (KPTI) · filed Jun 14, 2022
- Accession no.
- 0001209191-22-036812
- Filed
- Jun 14, 2022
- Trade date
- Jun 13, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $8.08K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cheng Sohanya RoshanCIK 0001865796 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | Common Stock | SSaleDisposed | −66 | $5.35 | −$353.1 | 91,434 | Direct | |
| Jun 13, 2022 | Common Stock | SSaleDisposed | −1,485 | $5.20 | −$7,722 | 89,949 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.